Search

Your search keyword '"Joshua Cohen"' showing total 15 results
Start Over Author "Joshua Cohen" Journal gynecologic oncology
15 results on '"Joshua Cohen"'

2. Genomic alterations, molecularly targeted therapy and race: Real world data from the Endometrial Cancer Molecularly Targeted Therapy Consortium (LBA 8)

Author

Angeles Alvarez Secord, Bhavana Pothuri, Floor Backes, Premal Thaker, Paola Gehrig, Rebecca Previs, Lindsay Borden, Samantha Thomas, Amanda Jackson, Gottfried Konecny, Linda Duska, Rebecca Arend, Jason Wright, Bradley Corr, G. Larry Maxwell, Casey Cosgrove, Mary Mullen, Kathleen Moore, Thomas Herzog, Joshua Cohen, Allison Gockley, Stephanie Gaillard, Amanda Fader, Andrew Berchuck, and Victoria Bae-Jump

Subjects
Oncology, Obstetrics and Gynecology
Published
2022
Full Text
View/download PDF

11. The impact of age, race, and HPV status on the increasing incidence of cervical adenocarcinoma in U.S. women

Author

John K. Chan, Daniel S. Kapp, Kathleen Darcy, Cheng-I Liao, Michael Richardson, Chunqiao Tian, K Furey, Joshua Cohen, and Amandeep Mann

Subjects
Hysterectomy, Behavioral Risk Factor Surveillance System, National Health and Nutrition Examination Survey, business.industry, Incidence (epidemiology), medicine.medical_treatment, Obstetrics and Gynecology, Disease, medicine.disease, Annual Percent Change, Oncology, Cohort, Medicine, Adenocarcinoma, business, Demography
Abstract

Objectives: To evaluate the demographic and HPV status in relation to the increasing incidence of adenocarcinoma in the United States. Methods: Data were obtained from the United States Cancer Statistics from 2001 to 2016. SEER*Stat and Joinpoint regression were used to calculate average annual percent change (AAPC). Incidence rates were corrected for hysterectomy using the Behavioral Risk Factor Surveillance System. THe National Health and Nutrition Examination Survey (NHANES) was used to evaluate HPV genotypes in a healthy cohort. Results: Of 201,609 patients with cervical adenocarcinoma between 2001-2016, White, Black, Hispanic, Asian and others comprised 62%, 15.4%, 16.3%, 4.4% and 1.8% of patients. Overall the 40-44 year-old age groups had the highest incidence (2.97 / 100,000). We also found an average annual increase of 2.4% in this age group. (p or =5 partners. Although HPV 16 was the predominant HPV genotype at 18.4%, HPV 18 comprised 9.1% of the HPV positive patients within the study group. Blacks have a two-fold higher rate of HPV 18 infection (3.2% vs 1.3%; p Download : Download high-res image (320KB) Download : Download full-size image Conclusions: The incidence of adenocarcinoma is increasing in the United States. Blacks have a higher incidence of metastatic disease compared to Whites and other races. HPV 18 genotypes were more prevalent in Blacks compared to Whites with no difference HPV 16.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results